Abemaciclib is a type of cancer growth blocker that targets the proteins cyclin dependant kinase 4 and 6 (CDK4 and CDK6) on breast cancer cells. CDK 4 and CDK 6 are proteins that stimulate cancer cells to divide and grow. Abemaciclib works by blocking these proteins. It aims to slow or stop the growth of the cancer.
Apr 8, 2024
People also ask
Is abemaciclib considered chemotherapy?
Does abemaciclib cause weight loss?
What foods should you avoid while taking abemaciclib?
How common is hair loss with abemaciclib?
Jun 15, 2023 · Abemaciclib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.
Jan 31, 2024 · Abemaciclib is used together with tamoxifen or an aromatase inhibitor (eg, anastrozole, exemestane, letrozole) to treat hormone receptor (HR)-positive, HER-2 ...
VERZENIO® (abemaciclib) is indicated: • in combination with endocrine therapy (tamoxifen or an aromatase inhibitor) for the adjuvant treatment of adult patients ...
The recommended dose of abemaciclib is 150 mg twice daily when used in combination with endocrine therapy. Please refer to the summary of product ...
Indicated as monotherapy for adults with HR-positive, HER2-negative advanced or metastatic breast cancer with disease progression following endocrine therapy ...
Abemaciclib is a medication used to treat HR+ HER2- advanced or metastatic breast cancer. Abemaciclib is an antitumor agent and dual inhibitor of cyclin- ...
May 1, 2020 · Abemaciclib is an orally administered, selective, reversible small-molecule inhibitor of cyclin-dependent kinases. (CDK) 4 and 6.
Verzenio (abemaciclib) is a treatment for both HR+, HER2-, high risk, node positive early breast cancer and for certain types of HR+, HER2- metastatic ...
VERZENIO™ (abemaciclib) is indicated: in combination with fulvestrant for the treatment of women with hormone receptor (HR)-positive, human epidermal growth ...
